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Birt-Hogg-Dube syndrome (BHDS) is a rare form of classically cystic lung disease that may present with
spontaneous pneumothorax. The associated skin manifestations (ﬁbrofolliculomas) are not always pre-
sent. This article describes a case of spontaneous pneumothorax secondary to bullous emphysema in an
otherwise healthy gentleman caused by a novel mutation in the folliculin (FLCN) gene.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Case presentation
In November 2012, a 46 year old man was referred for assess-
ment of spontaneous pneumothoraces pending an upcoming bul-
lectomy by thoracic surgery. This gentleman had a past medical
history of recurrent pneumothoracies, asthma diagnosed in child-
hood, eczema, depression and anxiety. His only current medication
was duloxetine 30mg daily. His pneumothoraces began 24 years
ago, the ﬁrst of which was a tension pneumothorax he developed
after contact in a rugby game at the age of 22. He has had 7
spontaneous pneumothoraces in total, 3 of which were treated
with a chest tube. He underwent a right bullectomy in 1996 and,
after being assessed in our clinic, proceeded with left bullectomy
with subtotal parietal pleurectomy later in November 2012. At time
of assessment, he was asymptomatic. He had no cough, dyspnea,
chest pain, or exercise limitations.
He is a lifelong non-smoker and has no work place or hobby
exposures. His family history is positive for a mother with colon
cancer diagnosed at the age of 45 and a sister with spontaneous
pneumothoraces. There was no history of renal neoplasms in the
family.
His physical exam was normal with no evidence of skin lesions,
abdominal masses, or hypertension.Ltd. This is an open access article uPulmonary investigations included pulmonary function tests
(PFTs), thoracic computed tomography (CT), and surgical lung bi-
opsy. PFTs demonstrated a total lung capacity of 6.65 L (93% pre-
dicted), a reduced forced vital capacity (FVC) of 3.44 L (68% of
predicted [normal 80%]), and a reduced forced expiratory volume
in 1s (FEV1) of 1.96 L (49% of predicted [normal 80%]); there was
evidence of airﬂow obstruction, with a FEV1/FVC ratio of 57%
(normal 70%). Post bronchodilator, his FEV1 improved to 2.70 L
(67% predicted) which is a 38% improvement. His diffusing capacity
for carbon monoxide (DLCO) was normal at 74% predicted.
A CT scan showed multiple, bilateral cysts in varying sizes and
shapes with the largest measuring 10 cmwithin the left lower lobe
(Fig. 1). With regards to craniocaudal distribution, there was a basal
predominance. With regards to axial distribution, the cysts were
diffuse with no central or peripheral predominance. The cysts
demonstrated variable morphology with many of the larger
supleural cysts within the lower lobes demonstrating lobulated,
septated appearance. Intervening parenchyma appeared unre-
markable without nodules, ground glass, septal thickening or
honeycombing.
The patient was diagnosed with asthma and started on bude-
sonide/formoterol fumarate turbuhaler 200/6 mcg 2 inhalations
twice daily, sent for asthma education, and referred to a Geneticist.
The patient was counselled that his uncontrolled asthma may be
contributing to bullae enlarging and risk of spontaneous pneu-
mothorax. Pathological samples of lung tissue obtained during his
left bullectomy showed benign lung parenchyma with subpleuralnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Patient's presenting CT scan of the thorax demonstrating multiple, lobulated, septated bilateral cysts in varying sizes and shapes with a basal predominance.
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mation. No cystic lesions were identiﬁed despite two large samples
being obtained from the left upper and lower lobes.
Based on the clinical presentation, family history, and CT results,
the patient's diagnosis was most compatible with Birt-Hogg-Dube
syndrome (BHDS) syndrome. Genetic testing revealed a delete-
rious mutation (c.1219delA) in his folliculin (FLCN) gene. He has had
no post-surgical complications and abdominal CT showed normal
sized kidneys with no renal lesions. His immediate family members
were referred to a Geneticist for consideration of screening.2. Discussion
BHDS is a rare autosomal dominant genodermatosis that
described in 1977 as the triad of multifocal kidney cancer, pulmo-
nary cysts, and ﬁbrofolliculomas by three Canadian physicians [1].
While the ﬁbrofolliculomas are classical of BHDS, only two thirds of
BHDS patients will develop these lesions [2]. Lung involvement is
seen in 80% of BHDS patients and spontaneous pneumothorax is
the presenting feature in 25% of patients [3]. Renal cancer has
variable penetrance in BHDS with 30% of patients developing sol-
itary or multi-focal lesions [4]. Although not classically described in
the triad, the original case reports of a BHDS like syndrome
included generalized ﬁbrofolliculomas and colonic polyps [5,6] and
one case series found an incidence of colonic lesions (polyps or GI
cancer) in 30% of BHDS patients [2].
The radiological lung ﬁndings in classical BHDS vary in severity
but, if present, may show lentiform-shaped cysts that predominatein the lung bases and periphery and abut or include the proximal
portions of the lower lobe pulmonary arteries and veins [7,8]. In the
absence of extra-pulmonary manifestations that may help conﬁrm
BHDS, the lower zone location of cysts abuting vessels, lentiform
cysts with or without septae, and absence of emphysema strongly
suggest BHDS [7]. A family history of spontaneous pneumothorax
should also raise strong suspicion for BHDS among the other causes
of familial spontaneous pneumothorax which include Marfan
syndrome, Homocystinuria, EhlerseDanlos syndrome, and a1-
Antitrypsin deﬁciency [9]. This patient had multiple large bullae
with septae in addition to smaller, more typical, cysts and we hy-
pothesized that his untreated airﬂow obstruction from asthma
predisposed bullae formation. Regardless of etiology, the pleuro-
ulomonary pathology of multiple pleural blebs and large subpleural
bullae with pleural changes consistent with pneumothorax has
been described [10] and, while not speciﬁc, these changes are rare
in the absence of emphysematous changes outside of BHDS.
Molecular genetic testing for BHDS is the gold standard and can
detect 88% of the mutations thought to cause BHDS [11]. Genetic
testing to conﬁrm the disease should be considered, even in highly
suspicious cases, unless the patient has the other major criteria for
diagnosis of BHDS (at least 5 adult onset ﬁbrofolliculomas) [12]. In
addition, The European BHDS Consortium suggests it is reasonable
to order genetic testing on any patients with characteristic skin
lesions, cystic lung disease of no apparent cause, spontaneous
pneumothorax, early onset renal cancer, or a ﬁrst degree relative
with any of the prior features. A clinical diagnosis of BHDS can be
made if a patient fulﬁlls 1 major or 2 minor criteria from Table 1
Table 1
Criteria to diagnose BHDS [12].
Major criteria
At least ﬁve ﬁbrofolliculomas or trichodiscomas, at least one histologically conﬁrmed, of adult onset
Pathologic FLCN germline mutation
Minor Criteria
Multiple lung cysts: bilateral basally located lung cysts with no other apparent cause, with or without spontaneous pneumothorax
Renal cancer: early onset (<50 years) or multifocal or bilateral renal cancer, or renal cancer of mixed chromophobe and oncocytic histology
A ﬁrst degree relative with BHDS
A clinical diagnosis can be made of BHDS if a patient fulﬁlls 1 major or 2 minor criteria.
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The pathological ﬁndings in BHDS are caused by a loss of func-
tion mutation in the tumor suppressor gene FLCN which expresses
the protein folliculin [13]. Our patient was found to have a novel
FLCN mutation (c.1219delA) which has not been previously re-
ported. This mutation causes a frameshift starting with codon
Serine 407 creating a premature Stop codon at position 61 of the
new reading frame (p.Ser407AlafsX61). This mutation is predicted
to cause loss of normal protein function, either through protein
truncation or nonsense-mediated mRNA decay. Fortunately for our
patient, it has been suggested that patients with a C-deleterious
mutation maybe have a ﬁve-fold less risk of developing a renal
neoplasm compared to patients with a C-insertion mutation [14].
Annual screening for renal tumors with ultrasound is common
despite evidence that it is not sensitive enough to detect smaller
lesions [15]. Although CT is much more sensitive than U/S for
detecting lesions 1.5e2cm (100% vs. 58%) [15], the lifetime dose of
radiation would be unacceptably high. Therefore, screening with
renal MRI is recommended over U/S if it's available [12] although
there are no guidelines on the frequency of screening needed. As
the mean age of presentation with kidney cancer is 48e51 years in
BHDS (standard deviation 11.7 years, range 31e74 years) [14,16], at
our center we offer renal MRI screening at the age of 30 and repeat
it every 4e5 years in the absence of symptoms. Currently, the
recommendation is patients do not need more frequent colon
cancer screening than the general population.
An accurate diagnosis of BHDS is important to guide prognosis,
management including screening, and family counselling. While
there is no current treatment for BHDS, early detection of operable
renal cancers remains an important part of surveillance. Animal
studies in BHDS knockout mice have shown a survival beneﬁt with
treatment using sirolimus [17] and clinical trials using topical
sirolimus to treat ﬁbrofolliculomas are underway [18].3. Conclusion
The present report described an unusual cause of spontaneous
pneumothorax in the setting of bullous lung disease caused by
BHDS and reports a novel mutation in the FLCN gene causing this
clinical syndrome. We recommend genetic testing for BHDS in any
patient with unexplained lower lobe bullous lung disease even in
the absence of cystic lesions on pathological specimen.
Written informed consent was provided by the patient to sub-
mit this manuscript and can be provided at the editor's request.Conﬂict of interest
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